Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on April 22, 2025
Cardiac Marker Analyzer Market Expected to Achieve a Strong 5.44% CAGR, to Reach USD 6.3 Billion by 2035
EIN Presswire
·
April 22, 2025
Rising Geriatric Population: With aging comes increased susceptibility to cardiovascular diseases. US, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Cardiac marker analyzers play a crucial role in modern cardiovascular care, enabling rapid and …
Artificial Intelligence (AI) In Wound Care Market projected to surpass $7.65 billion by 2030 by 2030 at a CAGR of 18.33%
EIN Presswire
·
April 22, 2025
The artificial intelligence (AI) in the wound care market is anticipated to grow at a CAGR of 18.33% from US$3.32 billion in 2025 to US$7.65 billion by 2030. NEW YORK, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- According to a new study …
Central Precocious Puberty (CPP) Treatment Market estimated to reach US$2,384.872 million by 2030 at a CAGR of 7.84%
EIN Presswire
·
April 22, 2025
The central precocious puberty (CPP) treatment market is anticipated to grow at a CAGR of 7.84% from $1,634.872 million in 2025 to $2,384.872 million by 2030. NEW YORK, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- According to a new study …
Cognitive Diagnostics Market anticipated to reach US$195.061 billion by 2030 at a CAGR of 7.21%
EIN Presswire
·
April 22, 2025
The cognitive diagnostics market is anticipated to grow at a CAGR of 7.21% from US$137.738 billion in 2025 to US$195.061 billion by 2030. NEW YORK, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- According to a new study published by Knowledge …
Blood Pressure Cuffs Market Set to Hit USD 4.5 Billion by 2035, Driven by Rising Cardiovascular Health Focus | MRFR
EIN Presswire
·
April 22, 2025
Blood Pressure Cuffs Market to reach USD 4.5B by 2035, driven by growing cardiovascular health focus and steady 3.24% CAGR, according to MRFR. US, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- The global Blood Pressure Cuffs Market is …
Computer-Aided Drug Discovery Market projected to achieve a CAGR of 11.59% to reach US$10.306 billion by 2030
EIN Presswire
·
April 22, 2025
The computer-aided drug discovery market is anticipated to grow at a CAGR of 11.59% from US$5.955 billion in 2025 to US$10.306 billion by 2030. NEW YORK, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- According to a new study published by …
Epigenetics Drugs And Diagnostic Technologies Market anticipated to surpass $53.345 billion by 2030 at a CAGR of 15.21%
EIN Presswire
·
April 22, 2025
The epigenetics drugs and diagnostic technologies market is anticipated to grow at a CAGR of 15.21% from US$26.283 billion in 2025 to US$53.345 billion by 2030. NEW YORK, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- According to a new study …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 22, 2025
NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of …
Clover Health Announces Changes to Board of Directors
GlobeNewswire
·
April 22, 2025
WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s …
Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro
GlobeNewswire
·
April 22, 2025
Lakeland, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide Alternative Without the Injections, Prescription Costs, or Side Effects Introduction …
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
April 22, 2025
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first …
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
GlobeNewswire
·
April 22, 2025
DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, …
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
GlobeNewswire
·
April 22, 2025
LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First …
The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
GlobeNewswire
·
April 22, 2025
CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with …
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
GlobeNewswire
·
April 22, 2025
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, France Phase 3 ABTECT induction trials remain on track: enrollment completion …
Sight Sciences Appoints Gary Burbach to its Board of Directors
GlobeNewswire
·
April 22, 2025
MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the …
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
GlobeNewswire
·
April 22, 2025
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in …
Intuitive Announces First Quarter Earnings
GlobeNewswire
·
April 22, 2025
SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March …
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario
GlobeNewswire
·
April 22, 2025
TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering regenerative exosomes-based therapies for central …
Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025
GlobeNewswire
·
April 22, 2025
MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company …